Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
April-2018 Volume 17 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2018 Volume 17 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Hepatocyte growth factor improves bone regeneration via the bone morphogenetic protein‑2‑mediated NF‑κB signaling pathway

  • Authors:
    • Ruixin Zhen
    • Jianing Yang
    • Yu Wang
    • Yubo Li
    • Bin Chen
    • Youxin Song
    • Guiyun Ma
    • Bo Yang
  • View Affiliations / Copyright

    Affiliations: Department of Spinal Surgery, Chengde Medical College Affiliated Hospital, Chengde, Hebei 067000, P.R. China
  • Pages: 6045-6053
    |
    Published online on: February 6, 2018
       https://doi.org/10.3892/mmr.2018.8559
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Bone regeneration is an important process associated with the treatment of osteonecrosis, which is caused by various factors. Hepatocyte growth factor (HGF) is an active biological factor that has multifunctional roles in cell biology, life sciences and clinical medicine. It has previously been suggested that bone morphogenetic protein (BMP)‑2 exerts beneficial roles in bone formation, repair and angiogenesis in the femoral head. The present study aimed to investigate the benefits and molecular mechanisms of HGF in bone regeneration. The viability of osteoblasts and osteoclasts were studied in vitro. In addition, the expression levels of tumor necrosis factor (TNF)‑α, monocyte chemotactic protein (MCP)‑1, interleukin (IL)‑1 and IL‑6 were detected in a mouse fracture model following treatment with HGF. The expression and activity of nuclear factor (NF)‑κB were also analyzed in osteocytes post‑treatment with HGF. Histological analysis was used to determine the therapeutic effects of HGF on mice with fractures. The migration and differentiation of osteoblasts and osteoclasts were investigated in HGF‑incubated cells. Furthermore, angiogenesis and BMP‑2 expression were analyzed in the mouse fracture model post‑treatment with HGF. The results indicated that HGF regulates the cell viability of osteoblasts and osteoclasts, and also balanced the ratio between osteoblasts and osteoclasts. In addition, HGF decreased the serum expression levels of TNF‑α, MCP‑1, IL‑1 and IL‑6 in experimental mice. The results of a mechanistic analysis demonstrated that HGF upregulated p65, IκB kinase‑β and IκBα expression in osteoblasts from experimental mice. In addition, the expression levels of vascular endothelial growth factor, BMP‑2 receptor, receptor activator of NF‑κB ligand and macrophage colony‑stimulating factor were upregulated by HGF, which may effectively promote blood vessel regeneration, and contribute to the formation and revascularization of tissue‑engineered bone. Furthermore, HGF promoted BMP‑2 expression and enhanced angiogenesis at the fracture location. These results suggested that HGF treatment may significantly promote bone regeneration in a mouse fracture model. In conclusion, these results indicated that HGF is involved in bone regeneration, angiogenesis and the balance between osteoblasts and osteoclasts, thus suggesting that HGF may be considered a potential agent for the treatment of fractures via the promotion of bone regeneration through regulation of the BMP‑2‑mediated NF‑κB signaling pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Furuya H, Tabata Y and Kaneko K: Bone regeneration for murine femur fracture by gelatin hydrogels incorporating basic fibroblast growth factor with different release profiles. Tissue Eng Part A. 20:1531–1541. 2014. View Article : Google Scholar : PubMed/NCBI

2 

Wang X, Wang Y, Gou W, Lu Q, Peng J and Lu S: Role of mesenchymal stem cells in bone regeneration and fracture repair: A review. Int Orthop. 37:2491–2498. 2013. View Article : Google Scholar : PubMed/NCBI

3 

Thorimbert V, König D, Marro J, Ruggiero F and Jaźwińska A: Bone morphogenetic protein signaling promotes morphogenesis of blood vessels, wound epidermis, and actinotrichia during fin regeneration in zebrafish. FASEB J. 29:4299–4312. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Perez RA, Kim JH, Buitrago JO, Wall IB and Kim HW: Novel therapeutic core-shell hydrogel scaffolds with sequential delivery of cobalt and bone morphogenetic protein-2 for synergistic bone regeneration. Acta Biomater. 23:295–308. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Rozen N, Lewinson D, Bick T, Meretyk S and Soudry M: Role of bone regeneration and turnover modulators in control of fracture. Crit Rev Eukaryot Gene Expr. 17:197–213. 2007. View Article : Google Scholar : PubMed/NCBI

6 

Hutchison C, Pilote M and Roy S: The axolotl limb: A model for bone development, regeneration and fracture healing. Bone. 40:45–56. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Hankenson KD, Gagne K and Shaughnessy M: Extracellular signaling molecules to promote fracture healing and bone regeneration. Adv Drug Deliv Rev. 94:3–12. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Suzuki A, Uemura T and Nakamura H: Control of bone remodeling by nervous system. Neural involvement in fracture healing and bone regeneration. Clin Calcium. 20:1820–1827. 2010.(In Japanese).

9 

Tewari D, Khan MP, Sagar N, China SP, Singh AK, Kheruka SC, Barai S, Tewari MC, Nagar GK, Vishwakarma AL, et al: Ovariectomized rats with established osteopenia have diminished mesenchymal stem cells in the bone marrow and impaired homing, osteoinduction and bone regeneration at the fracture site. Stem Cell Rev. 11:309–321. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Ramezani A, Nägga K, Hansson O, Lönn J, Sjöwall J, Katoozian F, Mansouri S and Nayeri F: Hepatocyte growth factor in cerebrospinal fluid differentiates community-acquired or nosocomial septic meningitis from other causes of pleocytosis. Fluids Barriers CNS. 12:222015. View Article : Google Scholar : PubMed/NCBI

11 

Faletto DL, Kaplan DR, Halverson DO, Rosen EM and Vande Woude GF: Signal transduction in c-met mediated motogenesis. EXS. 65:107–130. 1993.PubMed/NCBI

12 

Baum E, Pawlaczyk K, Mackowiak B, Maćkowiak B, Sosinska P, Matecka M, Kolodziejczak B, Musielak M and Breborowicz A: Levels of hepatocyte growth factor in serum correlate with quality of life in hemodialysis patients. Int J Clin Exp Pathol. 8:13477–13482. 2015.PubMed/NCBI

13 

Mizuno S and Nakamura T: Molecular basis for HGF-mediated regression of renal fibrosis. Nihon Rinsho. 64 Suppl 2:S312–S321. 2006.

14 

Zhang SH, Wen KM, Wu W, Li WY and Zhao JN: Efficacy of HGF carried by ultrasound microbubble-cationic nano-liposomes complex for treating hepatic fibrosis in a bile duct ligation rat model, and its relationship with the diffusion-weighted MRI parameters. Clin Res Hepatol Gastroenterol. 37:602–607. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Singh K, Massel DH, Mayo BC, Bohl DD, Long WW and Modi KD: Bone morphogenetic proteins in lumbar arthrodesis: What is all the debate about? Commentary on an article by Daniel C. Beachler, PhD, MHS et al: ‘Bone morphogenetic protein use and cancer risk among patients undergoing lumbar arthrodesis: A case-cohort study using the SEER-medicare database’. J Bone Joint Surg Am. 98:e572016. View Article : Google Scholar : PubMed/NCBI

16 

Yamamoto M, Hokugo A, Takahashi Y, Nakano T, Hiraoka M and Tabata Y: Combination of BMP-2-releasing gelatin/β-TCP sponges with autologous bone marrow for bone regeneration of X-ray-irradiated rabbit ulnar defects. Biomaterials. 56:18–25. 2015. View Article : Google Scholar : PubMed/NCBI

17 

Grcevic D, Jajic Z, Kovacic N, Lukic IK, Velagic V, Grubisic F, Ivcevic S and Marusic A: Peripheral blood expression profiles of bone morphogenetic proteins, tumor necrosis factor-superfamily molecules, and transcription factor Runx2 could be used as markers of the form of arthritis, disease activity, and therapeutic responsiveness. J Rheumatol. 37:246–256. 2010. View Article : Google Scholar : PubMed/NCBI

18 

Lories RJ and Luyten FP: Bone morphogenetic proteins in destructive and remodeling arthritis. Arthritis Res Ther. 9:2072007. View Article : Google Scholar : PubMed/NCBI

19 

Postigo J, Iglesias M, Álvarez P, Jesús Augustin J, Buelta L, Merino J and Merino R: Bone morphogenetic protein and activin membrane-bound inhibitor, a transforming growth factor β rheostat that controls murine treg cell/Th17 cell differentiation and the development of autoimmune arthritis by reducing interleukin-2 signaling. Arthritis Rheumatol. 68:1551–1562. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Brescia AC, Simonds MM, McCahan SM, Fawcett PT and Rose CD: The role of transforming growth factor β signaling in fibroblast-like synoviocytes from patients with oligoarticular juvenile idiopathic arthritis: Dysregulation of transforming growth factor β signaling, including overexpression of bone morphogenetic protein 4, may lead to a chondrocyte phenotype and may contribute to bony hypertrophy. Arthritis Rheumatol. 66:1352–1362. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Holstein JH, Schmalenbach J, Herrmann M, Ölkü I, Garcia P, Histing T, Herrmann W, Menger MD, Pohlemann T and Claes L: Excess dietary methionine does not affect fracture healing in mice. Med Sci Monit. 18:BR469–BR474. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Wan Q, Schoenmaker T, Jansen ID, Bian Z, de Vries TJ and Everts V: Osteoblasts of calvaria induce higher numbers of osteoclasts than osteoblasts from long bone. Bone. 86:10–21. 2016. View Article : Google Scholar : PubMed/NCBI

23 

Aino M, Nishida E, Fujieda Y, et al: Isolation and characterization of the human immature osteoblast culture system from the alveolar bones of aged donors for bone regeneration therapy. Expert Opin Biol Ther. 14:1731–1744. 2014. View Article : Google Scholar : PubMed/NCBI

24 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

25 

Wai-Hoe L, Wing-Seng L, Ismail Z and Lay-Harn G: SDS-PAGE-based quantitative assay for screening of kidney stone disease. Biol Proced Online. 11:145–160. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Bajnok A, Kaposi A, Kovács L, Vásárhelyi B, Balog A and Toldi G: Analysis by flow cytometry of calcium influx kinetics in peripheral lymphocytes of patients with rheumatoid arthritis. Cytometry A. 83:287–293. 2013. View Article : Google Scholar : PubMed/NCBI

27 

Kinsella S, Murphy K, Breen M, O'Neill S, McLaughlin P, Coyle J, Bogue C, O'Neill F, Moore N, McGarrigle A, et al: Comparison of single CT scan assessment of bone mineral density, vascular calcification and fat mass with standard clinical measurements in renal transplant subjects: The ABC HeART study. BMC Nephrol. 16:1882015. View Article : Google Scholar : PubMed/NCBI

28 

Morimoto Y, Hoshino H, Sakurai T, Terakawa S and Nagano A: Quantitative evaluation of bone resorption activity of osteoclast-like cells by measuring calcium phosphate resorbing area using incubator-facilitated and video-enhanced microscopy. Microsc Res Tech. 72:317–322. 2009. View Article : Google Scholar : PubMed/NCBI

29 

Thomas MV and Puleo DA: Infection, inflammation, and bone regeneration: A paradoxical relationship. J Dent Res. 90:1052–1061. 2011. View Article : Google Scholar : PubMed/NCBI

30 

Mallavia B, Recio C, Oguiza A, Ortiz-Muñoz G, Lazaro I, Lopez-Parra V, Lopez-Franco O, Schindler S, Depping R, Egido J and Gomez-Guerrero C: Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis. Am J Pathol. 182:1910–1921. 2013. View Article : Google Scholar : PubMed/NCBI

31 

Xinluan W, Yuxiao L, Helena NH, Zhijun Y and Ling Q: Systemic drug delivery systems for bone tissue regeneration-a mini review. Curr Pharm Des. 21:1575–1583. 2015. View Article : Google Scholar : PubMed/NCBI

32 

Gibbs DM, Black CR, Dawson JI and Oreffo RO: A review of hydrogel use in fracture healing and bone regeneration. J Tissue Eng Regen Med. 10:187–198. 2016. View Article : Google Scholar : PubMed/NCBI

33 

Tomson PL, Lumley PJ, Alexander MY, Smith AJ and Cooper PR: Hepatocyte growth factor is sequestered in dentine matrix and promotes regeneration-associated events in dental pulp cells. Cytokine. 61:622–629. 2013. View Article : Google Scholar : PubMed/NCBI

34 

Madonna R, Cevik C, Nasser M and De Caterina R: Hepatocyte growth factor: Molecular biomarker and player in cardioprotection and cardiovascular regeneration. Thromb Haemost. 107:656–661. 2012. View Article : Google Scholar : PubMed/NCBI

35 

Jin SZ, Meng XW, Sun X, Han MZ, Liu BR, Wang XH and Pei FH: Hepatocyte growth factor promotes liver regeneration induced by transfusion of bone marrow mononuclear cells in a murine acute liver failure model. J Hepatobiliary Pancreat Sci. 18:397–405. 2011. View Article : Google Scholar : PubMed/NCBI

36 

Izumida Y, Aoki T, Yasuda D, Koizumi T, Suganuma C, Saito K, Murai N, Shimizu Y, Hayashi K, Odaira M, et al: Hepatocyte growth factor is constitutively produced by donor-derived bone marrow cells and promotes regeneration of pancreatic beta-cells. Biochem Biophys Res Commun. 333:273–282. 2005. View Article : Google Scholar : PubMed/NCBI

37 

Harvey EJ: Knee trauma and posttraumatic osteoarthritis-more science needed: Commentary on an article by Justin M. Haller, MD et al: ‘Inflammatory cytokine response following acute tibial plateau fracture’. J Bone Joint Surg Am. 97:e332015. View Article : Google Scholar : PubMed/NCBI

38 

Haller JM, McFadden M, Kubiak EN and Higgins TF: Inflammatory cytokine response following acute tibial plateau fracture. J Bone Joint Surg Am. 97:478–483. 2015. View Article : Google Scholar : PubMed/NCBI

39 

Marino M, Palmieri G, Peruzzi M, Scuderi F and Bartoccioni E: A study of inflammatory/necrosis biomarkers in the fracture of the femur treated with proximal femoral nail antirotation. Mediators Inflamm. 2015:1898642015. View Article : Google Scholar : PubMed/NCBI

40 

Coudriet GM, He J, Trucco M, Mars WM and Piganelli JD: Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: Implications for inflammatory mediated diseases. PLoS One. 5:e153842010. View Article : Google Scholar : PubMed/NCBI

41 

Boissinot M, Cleyrat C, Vilaine M, Jacques Y, Corre I and Hermouet S: Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F. Oncogene. 30:990–1001. 2011. View Article : Google Scholar : PubMed/NCBI

42 

Katz MS, Thatch KA and Schwartz MZ: Hepatocyte growth factor and omega-3-enriched feeds have a synergistic effect on mucosal mass in an animal model of inflammatory bowel disease. J Pediatr Surg. 47:194–198. 2012. View Article : Google Scholar : PubMed/NCBI

43 

da Silva CG, Maccariello ER, Wilson SW, Putheti P, Daniel S, Damrauer SM, Peterson CR, Siracuse JJ, Kaczmarek E and Ferran C: Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation. J Cell Physiol. 227:1382–1390. 2012. View Article : Google Scholar : PubMed/NCBI

44 

Sasikumar KP, Elavarasu S and Gadagi JS: The application of bone morphogenetic proteins to periodontal and peri-implant tissue regeneration: A literature review. J Pharm Bioallied Sci. 4 Suppl 2:S427–S430. 2012. View Article : Google Scholar : PubMed/NCBI

45 

Bragdon B, Moseychuk O, Saldanha S, King D, Julian J and Nohe A: Bone morphogenetic proteins: A critical review. Cell Signal. 23:609–620. 2011. View Article : Google Scholar : PubMed/NCBI

46 

Hustedt JW and Blizzard DJ: The controversy surrounding bone morphogenetic proteins in the spine: A review of current research. Yale J Biol Med. 87:549–561. 2014.PubMed/NCBI

47 

Dagostino PR, Whitmore RG, Smith GA, Maltenfort MG and Ratliff JK: Impact of bone morphogenetic proteins on frequency of revision surgery, use of autograft bone, and total hospital charges in surgery for lumbar degenerative disease: Review of the Nationwide inpatient sample from 2002 to 2008. Spine J. 14:20–30. 2014. View Article : Google Scholar : PubMed/NCBI

48 

Imai Y, Terai H, Nomura-Furuwatari C, Mizuno S, Matsumoto K, Nakamura T and Takaoka K: Hepatocyte growth factor contributes to fracture repair by upregulating the expression of BMP receptors. J Bone Miner Res. 20:1723–1730. 2005. View Article : Google Scholar : PubMed/NCBI

49 

Ye L, Lewis-Russell JM, Davies G, Sanders AJ, Kynaston H and Jiang WG: Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells. Int J Oncol. 30:521–529. 2007.PubMed/NCBI

50 

Okubo Y, Bessho K, Fujimura K, Kusumoto K, Ogawa Y and Iizuka T: Osteogenesis by recombinant human bone morphogenetic protein-2 at skeletal sites. Clin Orthop Relat Res. 1–301. 2000.

51 

Ozeç Y, Oztürk M, Kýlýç E, Yeler H, Göze F and Gümüş C: Effect of recombinant human bone morphogenetic protein-2 on mandibular distraction osteogenesis. J Craniofac Surg. 17:80–83. 2006. View Article : Google Scholar : PubMed/NCBI

52 

Marinova-Mutafchieva L, Taylor P, Funa K, Maini RN and Zvaifler NJ: Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis Rheum. 43:2046–2055. 2000. View Article : Google Scholar : PubMed/NCBI

53 

Issa JP, do Nascimento C, Lamano T, Iyomasa MM, Sebald W and de Albuquerque RF Jr: Effect of recombinant human bone morphogenetic protein-2 on bone formation in the acute distraction osteogenesis of rat mandibles. Clin Oral Implants Res. 20:1286–1292. 2009. View Article : Google Scholar : PubMed/NCBI

54 

Yonezawa H, Harada K, Ikebe T, Shinohara M and Enomoto S: Effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on bone consolidation on distraction osteogenesis: A preliminary study in rabbit mandibles. J Craniomaxillofac Surg. 34:270–276. 2006. View Article : Google Scholar : PubMed/NCBI

55 

Wang J, Wang K, Shi Z and Zhang M: Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 22:1161–1164. 2008.(In Chinese). PubMed/NCBI

56 

Sugimori K, Matsui K, Motomura H, Tokoro T, Wang J, Higa S, Kimura T and Kitajima I: BMP-2 prevents apoptosis of the N1511 chondrocytic cell line through PI3K/Akt-mediated NF-kappaB activation. J Bone Miner Metab. 23:411–419. 2005. View Article : Google Scholar : PubMed/NCBI

57 

Feng JQ, Xing L, Zhang JH, Zhao M, Horn D, Chan J, Boyce BF, Harris SE, Mundy GR and Chen D: NF-kappaB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro. J Biol Chem. 278:29130–29135. 2003. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhen R, Yang J, Wang Y, Li Y, Chen B, Song Y, Ma G and Yang B: Hepatocyte growth factor improves bone regeneration via the bone morphogenetic protein‑2‑mediated NF‑κB signaling pathway. Mol Med Rep 17: 6045-6053, 2018.
APA
Zhen, R., Yang, J., Wang, Y., Li, Y., Chen, B., Song, Y. ... Yang, B. (2018). Hepatocyte growth factor improves bone regeneration via the bone morphogenetic protein‑2‑mediated NF‑κB signaling pathway. Molecular Medicine Reports, 17, 6045-6053. https://doi.org/10.3892/mmr.2018.8559
MLA
Zhen, R., Yang, J., Wang, Y., Li, Y., Chen, B., Song, Y., Ma, G., Yang, B."Hepatocyte growth factor improves bone regeneration via the bone morphogenetic protein‑2‑mediated NF‑κB signaling pathway". Molecular Medicine Reports 17.4 (2018): 6045-6053.
Chicago
Zhen, R., Yang, J., Wang, Y., Li, Y., Chen, B., Song, Y., Ma, G., Yang, B."Hepatocyte growth factor improves bone regeneration via the bone morphogenetic protein‑2‑mediated NF‑κB signaling pathway". Molecular Medicine Reports 17, no. 4 (2018): 6045-6053. https://doi.org/10.3892/mmr.2018.8559
Copy and paste a formatted citation
x
Spandidos Publications style
Zhen R, Yang J, Wang Y, Li Y, Chen B, Song Y, Ma G and Yang B: Hepatocyte growth factor improves bone regeneration via the bone morphogenetic protein‑2‑mediated NF‑κB signaling pathway. Mol Med Rep 17: 6045-6053, 2018.
APA
Zhen, R., Yang, J., Wang, Y., Li, Y., Chen, B., Song, Y. ... Yang, B. (2018). Hepatocyte growth factor improves bone regeneration via the bone morphogenetic protein‑2‑mediated NF‑κB signaling pathway. Molecular Medicine Reports, 17, 6045-6053. https://doi.org/10.3892/mmr.2018.8559
MLA
Zhen, R., Yang, J., Wang, Y., Li, Y., Chen, B., Song, Y., Ma, G., Yang, B."Hepatocyte growth factor improves bone regeneration via the bone morphogenetic protein‑2‑mediated NF‑κB signaling pathway". Molecular Medicine Reports 17.4 (2018): 6045-6053.
Chicago
Zhen, R., Yang, J., Wang, Y., Li, Y., Chen, B., Song, Y., Ma, G., Yang, B."Hepatocyte growth factor improves bone regeneration via the bone morphogenetic protein‑2‑mediated NF‑κB signaling pathway". Molecular Medicine Reports 17, no. 4 (2018): 6045-6053. https://doi.org/10.3892/mmr.2018.8559
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team